Pulse Medical receives FDA BDD for its μFR system
May 30, 2023Medical Communications BDD, Cardiology, FDA, Pulse Medical
Shanghai, China-based Pulse Medical Technology has announced that its 4th generation μFR system has received Breakthrough Device Designation (BDD) from …
AstraZeneca’s Ultomiris approved in Japan for prevention of relapses in patients with NMOSD
May 30, 2023Medical Communications AstraZeneca, NMOSD, Neurology, Ultomiris
AstraZeneca has announced that Ultomiris (ravulizumab) has been approved in Japan as a long-acting C5 complement inhibitor for the prevention …
FDA approves first oral antiviral to treat adult patients with COVID-19
May 26, 2023Medical Communications COVID-19, FDA, Infections and infestations, paxlovid
The US Food and Drug Administration (FDA) has announced that it has approved the oral antiviral Paxlovid (nirmatrelvir tablets and …
Scientists use AI to find new antibiotic to fight superbug
May 26, 2023Research and Development AI, Microbiology, WHO, abaucin, antibiotic resistance
Scientists at McMaster University and the Massachusetts Institute of Technology (MIT) have utilised artificial intelligence (AI) in order to discover …
ZOLL remedē System receives FDA approval for sleep apnoea treatment
May 25, 2023Medical Communications Ear Nose & throat, FDA, ZOLL, sleep apnoea
ZOLL Medical Corporation has announced that it has received approval from the US Food and Drug Administration (FDA) for its …
BioInvent and Transgene announce positive phase 1a solid tumour trial data
May 25, 2023Research and Development BioInvent, Oncology, Transgene, clinical trials, oncology, tumours
Sweden-based BioInvent and French Transgene, both biotech companies, have reported positive phase 1a data from a trial studying BT-001 for …
ElevateBio announced $401m in Series D financing for cell and gene therapies
May 25, 2023Sales and Marketing ElevateBio, Financing, cell and gene therapies
US-based cell and gene therapy (CGT) company ElevateBio has announced that, at the end of its Series D financing led …
AstraZeneca shares oncology data at ASCO 2023
May 25, 2023Medical Communications ASCO, AstraZeneca, Cancer, Oncology, oncology
AstraZeneca plans to share data from its oncology pipeline at the American Society of Clinical Oncology (ASCO) Annual Meeting on …
Artivion receives FDA PMA approval of PerClot; transfers designation to Baxter
May 24, 2023Medical Communications Artivion, Baxter International, Cardiology, FDA, PMA, PerClot
US cardiac and vascular surgery company Artivion has announced that the US Food and Drug Administration (FDA) has granted a …
FDA approves Innoviva’s Xacduro for intravenous use
May 24, 2023Medical Communications FDA, Infections and infestations, Innoviva, pneumonia
Innoviva Specialty Therapeutics, a subsidiary of Innoviva, has announced that the US Food and Drug Administration (FDA) has approved Xacduro …
Rocket Pharmaceuticals granted FDA RMAT designation for gene therapy
May 24, 2023Medical Communications FDA, Haematology, RMAT, Rocket Pharmaceuticals, gene therapy
Rocket Pharmaceuticals, a US-based biotechnology company, has announced that it has received US Food and Drug Administration (FDA) Regenerative Medicine …
Touchlight completes expansion of one of world’s largest DNA manufacturing facilities in London
May 24, 2023Manufacturing and Production DNA, London, Manufacturing Facility, Touchlight, manufacturing
Touchlight, a company that focuses on pioneering enzymatic DNA production, has announced that it has completed the redevelopment and expansion …
More infections from contaminated eyedrops increase death toll
May 23, 2023Medical Communications FDA, Opthalmology, eyedrops, infections
The US Centers for Disease Control and Prevention (CDC) have released updated data regarding contaminated eyedrops. As of May 2023, …
FDA announces acceptance and priority review of NDA for LUMISIGHT imagining agent for breast cancer
May 23, 2023Research and Development FDA, Lumicell, Oncology, breast cancer, oncology
Lumicell has announced that the US Food and Drug Administration (FDA) has accepted and granted priority review for the New …
Grünenthal receives FDA Breakthrough Therapy Designation for knee osteoarthritis drug
May 23, 2023Medical Communications Breakthrough Therapy Designation, FDA, Grunenthal, Musculo-skeletal disorder, osteoarthritis
German pharmaceutical company Grünenthal has announced that the US Food and Drug Administration (FDA) has awarded it Breakthrough Therapy Designation …
FDA approves prescription nasal spray for opioid overdose treatment
May 23, 2023Medical Communications FDA, Nasal Spray, Opvee, Poisoning and drug dependency, opioids, overdose
The US Food and Drug Administration (FDA) has announced that it has approved Opvee, the first nalmefene hydrochloride nasal spray …
Oncimmune Holdings sells businesses to Freenome in £13m deal
May 22, 2023Sales and Marketing Freenome, Oncimmune Holdings, Oncology, acquisition
UK-based life sciences and immunodiagnostics firm Oncimmune Holdings has announced that it has sold its Oncimmune Limited and Oncimmune Europe …
FDA approves new insulin pump and algorithm software for enhanced automated insulin delivery
May 22, 2023Medical Communications Devices, FDA, diabetes, insulin
The US Food and Drug Administration (FDA) has announced that it has cleared the Beta Bionics iLet ACE Pump and …
Swing Therapeutics receives FDA authorisation for digital therapeutic for fibromyalgia
May 22, 2023Medical Communications CBT, Devices, FDA, Swing Therapeutics, fibromyalgia
Swing Therapeutics has announced that it has received De Novo marketing authorisation from the US Food and Drug Administration for …
Krystal Biotech secures FDA approval for redosable topical gene therapy
May 22, 2023Medical Communications FDA, Krystal Biotech, Paediatrics, dystrophic epidermolysis bullosa, gene therapy
US-based biotech company Krystal Biotech has announced that the US Food and Drug Administration (FDA) has approved its topical gene …
Latest content
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour
